Literature DB >> 16009866

Outcomes and cost of coronary artery bypass graft surgery in the United States and Canada.

Mark J Eisenberg1, Kristian B Filion, Arik Azoulay, Anya C Brox, Seema Haider, Louise Pilote.   

Abstract

BACKGROUND: We sought to determine whether there is a difference in in-hospital outcomes and costs for coronary artery bypass graft surgery (CABG) between the United States and Canada.
METHODS: We compared the outcomes and costs of treating 12 017 consecutive patients (4698 US and 7319 Canadian patients) undergoing CABG at 5 US and 4 Canadian hospitals. Participating hospitals used the same cost accounting system to provide patient-level clinical, resource utilization, and cost-of-treatment data (excluding physicians' fees). Canadian costs were converted to US dollars using purchasing power parities.
RESULTS: Compared with Canadian patients, US patients were older (mean +/- SD age, 68.0 +/- 10.4 vs 63.7 +/- 9.8 years [P<.001]), more likely to be female (27.4% vs 21.8% [P<.001]), and discharged from the hospital sooner (mean +/- SD length of stay, 8.7 +/- 0.1 vs 9.5 +/- 0.1 days [P<.001]). In-hospital costs of treatment were substantially higher in the United States than in Canada (mean +/- SD cost, dollar 20,673 +/- dollar 241 vs dollar 10,373 +/- dollar 123 [P<.001]; median, dollar 16,036 vs dollar 7880). After controlling for demographic and clinical differences, length of stay in Canada was 16.8% longer than in the United States; there was no difference in in-hospital mortality; and the cost in the United States was 82.5% higher than in Canada (P<.001).
CONCLUSIONS: The in-hospital cost of CABG in the United States is substantially higher than in Canada. This difference is due to higher direct and overhead costs in US hospitals, is not explained by demographic or clinical differences, and does not lead to superior clinical outcomes.

Entities:  

Mesh:

Year:  2005        PMID: 16009866     DOI: 10.1001/archinte.165.13.1506

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

1.  Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database.

Authors:  J Lachaine; A Gordon; M Choinière; J P Collet; D Dion; J-E Tarride
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

2.  Postoperative complications after elective coronary artery bypass grafting surgery in patients with sleep-disordered breathing.

Authors:  Maria Tafelmeier; Teresa Weizenegger; Sarah Ripfel; Miriam Fauser; Bernhard Floerchinger; Daniele Camboni; York Zausig; Sigrid Wittmann; Marzena A Drzymalski; Florian Zeman; Christof Schmid; Lars S Maier; Stefan Wagner; Michael Arzt
Journal:  Clin Res Cardiol       Date:  2018-06-12       Impact factor: 5.460

3.  Medical spending differences in the United States and Canada: the role of prices, procedures, and administrative expenses.

Authors:  Alexis Pozen; David M Cutler
Journal:  Inquiry       Date:  2010       Impact factor: 1.730

Review 4.  Small-diameter vascular tissue engineering.

Authors:  Dawit G Seifu; Agung Purnama; Kibret Mequanint; Diego Mantovani
Journal:  Nat Rev Cardiol       Date:  2013-05-21       Impact factor: 32.419

5.  Implications of Hemodialysis in Patients Undergoing Coronary Artery Bypass Grafting.

Authors:  Jimmy T Efird; Wesley T O'Neal; Catherine A Gouge; Linda C Kindell; Whitney L Kennedy; Paul Bolin; Jason B O'Neal; Curtis A Anderson; Evelio Rodriguez; T Bruce Ferguson; W Randolph Chitwood; Alan P Kypson
Journal:  Int J Cardiovasc Res       Date:  2013-03-13

6.  Relationship between maximum clot firmness in ROTEM® and postoperative bleeding after coronary artery bypass graft surgery in patients using clopidogrel.

Authors:  Rasoul Azarfarin; Fereidoon Noohi; Majid Kiavar; Ziae Totonchi; Avaz Heidarpour; Amir Hendiani; Zahra Sadat Koleini; Saeid Rahimi
Journal:  Ann Card Anaesth       Date:  2018 Apr-Jun

7.  Accounting for the relationship between per diem cost and LOS when estimating hospitalization costs.

Authors:  K Jack Ishak; Marilyn Stolar; Ming-yi Hu; Piedad Alvarez; Yamei Wang; Denis Getsios; Gregory C Williams
Journal:  BMC Health Serv Res       Date:  2012-12-01       Impact factor: 2.655

8.  The use of the transition cost accounting system in health services research.

Authors:  Arik Azoulay; Nadine M Doris; Kristian B Filion; Joanna Caron; Louise Pilote; Mark J Eisenberg
Journal:  Cost Eff Resour Alloc       Date:  2007-08-08

9.  Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to-high risk acute coronary syndrome and planned percutaneous coronary intervention.

Authors:  Vardhaman Patel; Fang-Ju Lin; Olaitan Ojo; Sapna Rao; Shengsheng Yu; Lin Zhan; Daniel R Touchette
Journal:  Pharm Pract (Granada)       Date:  2014-09-04

10.  Daily almond consumption in cardiovascular disease prevention via LDL-C change in the U.S. population: a cost-effectiveness analysis.

Authors:  Jifan Wang; Michelle A Lee Bravatti; Elizabeth J Johnson; Gowri Raman
Journal:  BMC Public Health       Date:  2020-04-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.